FDA approves Gamunex for CIDP

FDA approved an sBLA from Talecris ( Research Triangle Park, N.C.) for Gamunex immune globulin IV to treat chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Gamunex has Orphan Drug sta...